Pharmaceutical payments, increased prescribing go hand in hand

Financial payments from pharmaceutical companies were “consistently associated with increased prescribing” across a wide range of physician specialties, drug classes and prescribing decisions, according to the authors of a recent review.“All studies to date are unanimous: Accepting gifts from industry changes our prescribing and makes us worse doctors. Financial conflicts of interest with the drug industry are therefore contrary to our patients’ interests,” Aaron P. Mitchell, MD, MPH, a medical oncologist at the Memorial Sloan Kettering Cancer Center in New York City,Read More

Share on facebook
Share on twitter
Share on linkedin